Clinuvel Pharmaceuticals (ASX:CUV) used one of the world’s largest dermatology forums to sharpen its profile in pigmentary disorders, presenting new clinical insights and reinforcing the positioning of its lead therapy across both approved and investigational uses. …
Clinuvel spotlights vitiligo progress and long term safety data at major dermatology gathering
April 6, 2026 Australian Biotech
Latest Video
New Stories
-
GBMA White Paper calls for reforms to strengthen supply chain resilience
August 10, 2026 - - Latest News -
France the first to provide comprehensive reimbursement for GLP-1s for weight loss while Australia looks on
August 10, 2026 - -
New Zealand's ACT announces plan for pharmacies to do a lot more, but also ownership and location reform
August 10, 2026 - -
Achieving value is meaningless if it undermines access to medicines
August 10, 2026 - -
Australia’s 'Biggest Week in Biotech' brings global life sciences leaders to the Gold Coast
August 9, 2026 - - Australian Biotech -
The 'Dispatched' Podcast - Week in review
August 7, 2026 - - Podcast -
A new generation is rewriting their lives living with Cystic Fibrosis
August 7, 2026 - - Latest News